Earlier menarche is associated with a higher prevalence of Herpes simplex type-2 (HSV-2) in young women in rural Malawi

  1. Judith R Glynn  Is a corresponding author
  2. Ndoliwe Kayuni
  3. Levie Gondwe
  4. Alison J Price
  5. Amelia C Crampin
  1. London School of Hygiene and Tropical Medicine, United Kingdom
  2. Karonga Prevention Study, Malawi

Abstract

Remarkably little is known about associations between age at menarche and sexually transmitted infections, although girls with earlier menarche tend to have earlier sexual debut and school drop-out, so an association might be expected. In a population-based survey of >3000 women aged 15–30 in northern Malawi we show that those with earlier menarche had earlier sexual debut, earlier marriage and were more often Herpes simplex type-2 (HSV-2) positive. Compared to those with menarche aged <14, the age-adjusted odds ratios for HSV-2 were 0.89 (95%CI 0.71–1.1), 0.71 (0.57–0.89) and 0.69 (0.54–0.89) for menarche aged 14, 15 and 16+ respectively. This association persisted after adjusting for socio-economic factors, including schooling, and for sexual behaviour. No such association was seen with HIV infection, which is much less common and less uniformly distributed than HSV-2 in this population. The extra vulnerability of girls with earlier menarche needs to be recognised.

https://doi.org/10.7554/eLife.01604.001

eLife digest

For many girls in sub-Saharan Africa their first menstrual cycle can mean an abrupt end to childhood because a girl’s first period is often taken as a signal that she is ‘ready’ for sex and marriage. Most girls in this region have their first menstrual cycle between the ages of 13 and 18, with the median being around 15, and this is likely to get earlier as nutrition improves.

The age at which a girl in sub-Saharan Africa has her first period can have dramatic effects on her future prospects. Previous research in rural Malawi showed that more than half of those young women who had their first period before their 14th birthday never finish primary school and have sex before they are 16 years old. By comparison, 70% of women whose first menstrual cycle occurs at age 16 or older finish primary school and delay sex until after age 18.

To assess whether early menstruation might also be associated with the risk of contracting a sexually transmitted infection, Glynn et al. surveyed more than 3000 women between the ages of 15 and 30 in northern Malawi. Women who had their first menstrual cycle at an older age were less likely than those with an earlier onset of menstruation to be infected with Herpes simplex type-2. This difference persisted after adjustment for age at first sex and marriage, and for differences in socio-economic position, education and number of sexual partners. This may suggest that women with earlier onset of menstruation tended to have higher risk partnerships. There was no relationship between HIV and age at first menstrual cycle, probably because HIV is much less common than Herpes in the areas where the women lived.

Community and individual level interventions are needed to encourage and enable adolescent girls with early onset of menstruation to stay in school throughout puberty and beyond, and to help them reduce sexual risk taking from before their first sexual experiences.

https://doi.org/10.7554/eLife.01604.002

Introduction

When a girl reaches menarche she may be regarded by some societies as ‘ready’ to start sex and to marry (Sommer, 2009). This may be linked to initiation ceremonies, recognising the transition to adulthood (Munthali and Zulu, 2007). Puberty may change her own desires, and change the behaviour of those around her. In diverse settings, earlier age at menarche has been associated with earlier sexual debut and earlier marriage (Buga et al., 1996; Mensch et al., 2001; Downing and Bellis, 2009; Glynn et al., 2010; Boden et al., 2011). Earlier menarche is also associated with school drop-out in some settings (Biddlecom et al., 2008; Glynn et al., 2010; Boden et al., 2011).

An association between early menarche and sexually transmitted infections might therefore be expected, but there is limited direct evidence to support this. In Croatia earlier menarche was associated with Chlamydial infection among sexually active adolescents attending outpatients (Hirsl-Hecej et al., 2006); in Tanzania earlier menarche was associated with human papilloma virus (ter Meulen et al., 1992); and in a prospective study in New Zealand earlier menarche was associated with attendance at an STI clinic before age 18 (Boden et al., 2011). A small study in Uganda found no link between age at menarche and HIV incidence. (Quigley et al., 2000) Since first coitus before menarche has been identified as a risk factor for sexually transmitted infections (Duncan et al., 1994), earlier menarche could also be protective in certain situations.

In many populations the prevalence of Herpes simplex type-2 (HSV-2), an important co-factor for HIV acquisition (Glynn et al., 2009), rises quickly after onset of sexual activity, so it provides a useful marker of unprotected sex, especially in women in whom the prevalence can reach high levels (Obasi et al., 1999).

In a study in rural northern Malawi we have previously shown that earlier menarche leads to earlier sexual debut, earlier marriage, and earlier school drop-out (Glynn et al., 2010). Here we investigate the associations with HSV-2 and HIV infection. In this area, unlike southern Malawi (Morris, 2000; Munthali and Zulu, 2007), there are no initiation rituals associated with menarche. Girls experiencing their first period are traditionally sent to stay with an aunt or other female relative for instruction, and it is likely to become known in the community.

Results

Of 4772 women aged 15–30 who were eligible, 650 were not found and 146 refused to take part, leaving 3976, of whom 3965 were interviewed (83% of all those eligible). HIV results were available for 3651, and HSV-2 results for 3419. Those with missing HIV and HSV2 data were, on average, older, more educated, lived in better houses and experienced slightly later menarche.

Approximately one quarter of the women had menarche at each of <14, 14, 15 or ≥16 years of age. The associations between age at menarche, age at sexual debut and age at marriage are summarised in Figure 1. The age of sexual debut and the age at marriage increased with age at menarche. For example, among those with early menarche (age <14), 60% were married and only 16% were not yet sexually active at age 17, compared to 11% married and 71% not yet sexually active among those with late menarche (age ≥16).

Multistate lifetables showing proportion of young women who are still virgins, have started sex but are unmarried, and are married, by age and age at menarche.

Karonga District, Malawi.

https://doi.org/10.7554/eLife.01604.003

Overall 25.5% of those tested were HSV-2 positive and 5.6% were HIV positive. The risk of both infections increased rapidly with age (Figure 2). After adjusting for current age, HSV-2 infection was less common in those with later menarche than in those with earlier menarche (p-trend = 0.001) but there was no evidence for a linear trend between age at menarche and HIV infection (p-trend = 0.8) (Figure 3; Table 1).

Prevalence of HSV-2 and HIV infection in women by age, Karonga District, Malawi.
https://doi.org/10.7554/eLife.01604.004
Association between age at menarche and (A) HSV-2 and (B) HIV, adjusted for current age.

Karonga District, Malawi.

https://doi.org/10.7554/eLife.01604.005
Table 1

Risk factors for HSV2 and HIV infection in 15–30 year old women in a population survey, Karonga District, Malawi 2007–8

https://doi.org/10.7554/eLife.01604.006
HSV2HIV
n/N%OR (95% CI)Age adjustedn/N%OR (95% CI)Age adjusted
OR (95% CI)OR (95% CI)
All870/341925.5203/36515.6
Age
 15–9126/124010.2118/13141.41
 20–24276/107225.83.1 (2.4–3.9)64/11285.74.3 (2.6–7.4)
 25–30468/110742.36.5 (5.2–8.1)121/120910.08.0 (4.8–13.2)
Age at menarche
 <14245/81530.11151/8615.911
 14195/76925.40.79 (0.63–0.99)0.89 (0.71–1.1)43/8195.30.88 (0.60–1.3)1.0 (0.66–1.5)
 15225/96023.40.71 (0.58–0.88)0.71 (0.57–0.89)41/10304.00.66 (0.43–1.0)0.68 (0.44–1.0)
 ≥16157/62225.20.79 (0.62–0.99)0.69 (0.54–0.89)51/6657.71.3 (0.88–2.0)1.2 (0.81–1.8)
Age at first sex
 Never51/6398.00.21 (0.15–0.29)0.48 (0.33–0.69)10/6841.50.23 (0.12–0.44)0.69 (0.32–1.3)
 <16296/101429.21166/10766.111
 16–17235/79729.51.0 (0.83–1.2)0.99 (0.80–1.2)53/8476.31.0 (0.70–1.4)0.99 (0.68–1.5)
 18+273/93029.41.0 (0.83–1.2)0.76 (0.62–0.93)71/10027.11.2 (0.82–1.7)0.90 (0.63–1.3)
Marital status
 Never76/8269.21119/8852.211
 Current681/233029.24.1 (3.2–5.2)1.7 (1.3–2.3)133/24815.42.6 (1.6–4.2)0.78 (0.44–1.4)
 Previous113/26343.07.4 (5.3–10.4)3.4 (2.4–5.0)51/28517.99.9 (5.8–17.2)3.2 (1.7–5.9)
Lifetime no. of partners
 051/6398.00.33 (0.24–0.46)0.76 (0.53–1.1)10/6841.50.49 (0.25–0.98)1.4 (0.66–3.2)
 1304/147520.61146/15742.911
 2320/90035.62.1 (1.8–2.6)2.0 (1.7–2.4)82/9515.63.1 (2.2–4.5)2.9 (2.0–4.2)
 3139/28948.13.6 (2.7–4.6)3.2 (2.4–4.2)41/31313.15.0 (3.2–7.8)4.4 (2.8–6.8)
 ≥453/10749.53.8 (2.5–5.6)3.5 (2.3–5.3)24/12020.08.3 (4.9–14.2)7.4 (4.3–12.8)
Distance from road
 <1 km410/158925.811100/15956.311
 >1 km460/183025.10.97 (0.83–1.1)0.94 (0.80–1.1)62/18353.40.52 (0.38–0.72)0.50 (0.36–0.70)
Schooling
 None/Primary 1–5101/34729.1116/3784.211
 Primary 6–7215/88924.20.78 (0.59–1.0)0.88 (0.66–1.2)38/9454.00.95 (0.52–1.7)1.1 (0.59–2.0)
 Primary 8271/101126.80.89 (0.68–1.2)0.89 (0.67–1.2)58/10695.41.3 (0.74–2.3)1.3 (0.75–2.4)
 Secondary 1–3218/86025.40.83 (0.63–1.1)0.88 (0.65–1.2)70/9167.61.9 (1.1–3.3)2.0 (1.2–3.6)
 Secondary 4/Tertiary36/19618.40.55 (0.36–0.84)0.42 (0.27–0.66)18/2158.42.1 (1.0–4.1)1.8 (0.87–3.6)
Mother schooling
 <=Primary716/286125.011151/30215.011
 Secondary80/35222.70.88 (0.68–1.1)1.0 (0.76–1.3)30/3827.91.6 (1.1–2.4)1.8 (1.2–2.8)
Father schooling
 <=Primary517/204625.31194/21584.411
 Secondary260/109523.70.92 (0.78–1.1)0.96 (0.80–1.1)81/11667.01.6 (1.2–2.2)1.7 (1.3–2.3)
Housing quality
 1 (Best)148/66222.41171/7329.711
 2149/56526.41.2 (0.96–1.6)1.2 (0.89–1.5)32/5985.40.53 (0.34–0.81)0.48 (0.31–0.75)
 3317/123825.61.2 (0.96–1.5)1.0 (0.96–1.3)60/12964.60.45 (0.32–0.65)0.38 (0.26–0.55)
 4 (Worst)227/84326.91.3 (1.0–1.6)1.2 (0.96–1.6)38/9034.20.41 (0.27–0.61)0.37 (0.25–0.56)
Occupation
 Farmer652/222929.311143/23696.011
 In education63/7208.80.23 (0.18–0.31)0.55 (0.40–0.76)10/7671.30.21 (0.11–0.39)0.58 (0.28–1.2)
 Not working23/7729.91.0 (0.63–1.7)1.1 (0.66–1.9)8/889.11.6 (0.74–3.3)1.6 (0.77–3.5)
 Other102/27237.51.5 (1.1–1.9)1.3 (1.0–1.7)38/29313.02.3 (1.6–3.4)2.1 (1.4–3.1)
Times of insufficient food in household in last year
 No674/257526.211162/27485.911
 Yes166/72822.80.83 (0.69–1.0)0.83 (0.67–1.0)39/7755.00.85 (0.59–1.2)0.85 (0.59–1.2)
Times when can’t afford soap in last year
 No519/202125.711136/21666.311
 Yes321/128025.10.97 (0.82–1.1)0.97 (0.82–1.1)65/13554.80.75 (0.56–1.0)0.75 (0.55–1.0)
  1. OR = odds ratio

Some women who reported that they were not yet sexually active tested positive for HSV-2 and/or HIV (as previously noted) (Glynn et al., 2011). For both HSV-2 and HIV, the proportion positive increased with the lifetime number of partners, and was highest in those who had previously been married (divorced or widowed) and least common in those who had never married (Table 1).

HIV infection was more common near the main road; in those with more schooling, and whose parents had had more schooling; in those living in better-built houses; and in those working in the cash-economy. HSV-2 infection was equally common in the more distant areas as in the areas close to the road and was not associated with parental schooling or type of housing. It was least common among those with secondary or further education, and among those still in education. It was slightly less common among those who reported food insecurity. These trends persisted after adjusting for current age (Table 1).

Table 2 shows the effect of additionally adjusting the association of age at menarche with HSV-2 or HIV for socio-economic variables and sexual behaviour variables. It is restricted to those with no missing data for the factors included to allow possible mediation by these factors to be fully explored. As shown in Table 2, adjustment for socio-economic and behavioural factors made no difference to the associations with HIV and only slightly weakened the trend with HSV-2. The factors included are those that were independently associated with HSV-2 or HIV infection in a full model, or that confounded the association between age at menarche and HSV2 or HIV. Additional adjustment for the other factors shown in Table 1 made no further difference to the associations with HSV-2 or HIV.

Table 2

Association between age at menarche and HSV2 and HIV, adjusted for other variables, among 15–30 year-old women in Karonga District Malawi

https://doi.org/10.7554/eLife.01604.007
HSV2 (N = 3034)*HIV (N = 3231)*
Adjusted for ageAlso adjusted for socio-economic variablesAlso adjusted for behavioural variablesAdjusted for ageAlso adjusted for socio-economic variablesAlso adjusted for behavioural variables
OR (95% CI)OR (95% CI)OR (95% CI)OR (95% CI)OR (95% CI)OR (95% CI)
Age at menarche
<14111111
140.91 (0.72–1.2)0.92 (0.73–1.2)0.92 (0.72–1.2)0.97 (0.63–1.5)0.94 (0.61–1.4)0.96 (0.62–1.5)
150.73 (0.58–0.91)0.76 (0.60–0.95)0.77 (0.61–0.98)0.68 (0.44–1.0)0.64 (0.41–0.98)0.65 (0.42–1.0)
≥160.70 (0.54–0.89)0.75 (0.58–0.97)0.77 (0.59–1.0)1.2 (0.79–1.8)1.1 (0.69–1.6)1.1 (0.70–1.7)
  1. *

    To allow the effects of these potential mediators to be explored fully, the analysis is restricted to individuals with no missing data for the factors included.

  2. age, schooling, occupation, lack of food.

  3. age, schooling, occupation, lack of food, marital status, lifetime number of partners.

Discussion

Age at menarche in this population has a profound influence on adolescent trajectories through sexual debut and marriage. We have previously shown that early menarche is associated with school drop-out (Glynn et al., 2010). Here we show an association with HSV-2 infection, which is a marker of unprotected sex. The serological tests for HSV-2 have imperfect sensitivity and specificity (van Dyck et al., 2004), and since the resultant bias should be non-differential the true association with menarche could be stronger.

In our study this association was not explained by measured socio-economic or behavioural variables. This suggests that it was influenced by unmeasured factors, such as the risk groups of the partners, or by factors that we have measured imprecisely. Limitations in reported sexual behaviour are well known, with a tendency for women to under-report onset of sexual activity and number of partners (Buve et al., 2001; Glynn et al., 2011; Soler-Hampejsek et al., 2013). The failure to explain the association may also be explained by the limitations of a cross-sectional study. The outcome was HSV-2 prevalence, not incidence, and the time of the infection was unknown. The age at menarche depended on recall. This would not be influenced by HSV-2 status, but could be influenced by (recalled) age at marriage or sexual debut.

If the association between early menarche and HSV-2 infection is due to riskier behaviour or higher risk partners, an association with HIV infection might also be expected. Especially as HSV-2 infection and HIV infection are strongly associated, in this population (not shown) and elsewhere. (Glynn et al., 2009) However, as shown in Table 1, HIV is much less uniformly distributed in the population and much less common, so the risk of a woman acquiring HIV depends less directly on her own or her partner’s behaviour, and more on the local prevalence (and the probability that a given risk behaviour will lead to exposure to a partner with HIV infection), and on chance. The important role of population level rather than individual level risk factors for HIV has been shown in other settings (Gabrysch et al., 2008).

Early age at menarche appears to be a serious disadvantage to a girl’s life chances in this and other populations (Biddlecom et al., 2008; Downing and Bellis, 2009; Glynn et al., 2010). As nutrition improves, age at puberty decreases (Bellis et al., 2006). Unless society’s expectations of a girl’s role once she reaches puberty changes, increases in early sex, marriage and sexually transmitted infections can be expected. We have already discussed the need for community and individual level interventions to encourage and enable adolescent girls with early menarche to stay in school throughout puberty and beyond. To this should be added specific concerns over risky sexual behaviour in this group.

Methods

Demographic surveillance was established in a population of approximately 33,000 individuals living in one area of Karonga District, northern Malawi, in 2002. The surveillance uses local key informants who register births and deaths continuously, and report them periodically to project staff. There was a re-census 2 years after registration was completed, and then annually thereafter. Full details are provided elsewhere. (Jahn et al., 2007; Crampin et al., 2012) In 2007, after extensive piloting, a sexual behaviour survey was added to follow the annual re-census, together with a serosurvey for HIV and HSV-2. Each sexual behaviour interview was conducted in the local language, in private. Written informed consent was requested separately for the interview and the serosurvey (Glynn et al., 2011). Ethics permission for the study was received from the Malawi Health Sciences Research Committee and the ethics committee of the London School of Hygiene & Tropical Medicine.

Data from the first sexual behaviour survey round were used for this analysis. A question on age at menarche for women was added midway through the first round. For those with missing data on age at menarche from the first round, the response from the subsequent round was used. Other questions included the participant’s age at first sex, age at marriage, and number of partners, as well as schooling level and other socio-economic characteristics.

HSV-2 tests were conducted for women aged 15–30, using the type-2 specific enzyme immunoassay (Kalon Biological Ltd, Surrey, UK) which has the highest sensitivity and specificity of commercially available assays when used on African samples (van Dyck et al., 2004). HIV testing used rapid tests with the results immediately available to the participants (Floyd et al., 2013). We followed a parallel testing algorithm with Determine and Unigold, and SD-bioline as a tiebreaker if results were discordant, which we have previously shown to have very high sensitivity and specificity in this setting (Molesworth et al., 2010).

The association between age at menarche and ages at sexual debut and marriage were described using multistate life tables. The associations between age at menarche and other risk factors with HSV-2 and HIV were investigated using logistic regression. The extent to which the association between age at menarche and HSV-2 or HIV could be explained by measured behavioural and socio-economic factors was explored in multi-variable analyses, including these factors in the models, as appropriate. Analyses were done using STATA 12.1 (StataCorp, College Station, TX).

The data come from the Karonga Prevention study which has been conducting research in this population for more than 30 years. We have recently been awarded funding from the Wellcome Trust for a 4-year project to make our extensive data (on ∼300,000 individuals and >1 million participant contacts) more accessible, and to ensure that, as we continue to add to this unique resource, it remains usable, flexible and available to local and international researchers. This involves making major changes to the data structure, the user interface and the way new data are collected, whilst maintaining the integrity and relationships in the existing database. Meanwhile, a procedure for data sharing is in place, which requires the consent of the programme director in consultation with senior science staff. No reasonable data sharing requests are turned down and the programme is committed to ensuring as much access as possible to the data, while maintaining full confidentiality. Enquiries to Dr Mia Crampin (mia.crampin@lshtm.ac.uk).

Data availability

The following data sets were generated
    1. Crampin AC
    (2013)
    Karonga Prevention Study
    A procedure for data sharing is in place, which requires the consent of the programme director in consultation with senior science staff. No reasonable data sharing requests are turned down and the programme is committed to ensuring as much access as possible to the data, while maintaining full confidentiality. Enquiries to Dr Mia Crampin (mia.crampin@lshtm.ac.uk).

References

    1. Buga GA
    2. Amoko DH
    3. Ncayiyana DJ
    (1996)
    Sexual behaviour, contraceptive practice and reproductive health among school adolescents in rural Transkei
    South African Medical Journal 86:523–527.
    1. Hirsl-Hecej V
    2. Pustisek N
    3. Sikanic-Dugic N
    4. Domljan LM
    5. Kani D
    (2006)
    Prevalence of chlamydial genital infection and associated risk factors in adolescent females at an urban reproductive health care center in Croatia
    Collegium Antropologicum 30:131–137.
  1. Book
    1. Morris B
    (2000)
    Animals and ancestors. An ethnography
    Oxford, Berg.
    1. Quigley MA
    2. Morgan D
    3. Malamba SS
    4. Mayanja B
    5. Okongo MJ
    6. Carpenter LM
    7. Whitworth JA
    (2000)
    Case-control study of risk factors for incident HIV infection in rural Uganda
    Journal of Acquired Immune Deficiency Syndrome 23:418–425.

Article and author information

Author details

  1. Judith R Glynn

    Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom
    Contribution
    JRG, Conception and design, Analysis and interpretation of data, Drafting or revising the article
    For correspondence
    judith.glynn@lshtm.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
  2. Ndoliwe Kayuni

    Karonga Prevention Study, Chilumba, Malawi
    Contribution
    NK, Acquisition of data, Drafting or revising the article
    Competing interests
    The authors declare that no competing interests exist.
  3. Levie Gondwe

    Karonga Prevention Study, Chilumba, Malawi
    Contribution
    LG, Acquisition of data, Drafting or revising the article
    Competing interests
    The authors declare that no competing interests exist.
  4. Alison J Price

    1. Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom
    2. Karonga Prevention Study, Chilumba, Malawi
    Contribution
    AJP, Acquisition of data, Drafting or revising the article
    Competing interests
    The authors declare that no competing interests exist.
  5. Amelia C Crampin

    1. Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom
    2. Karonga Prevention Study, Chilumba, Malawi
    Contribution
    ACC, Conception and design, Acquisition of data, Drafting or revising the article
    Competing interests
    The authors declare that no competing interests exist.

Funding

Wellcome Trust (079828/Z/06)

  • Judith R Glynn

The funder had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Acknowledgements

We thank the Government of the Republic of Malawi for their interest in this Project and the National Health Sciences Research Committee of Malawi for permission to publish the paper.

Ethics

Human subjects: Written informed consent was requested separately for the interview and the serosurvey. Ethics permission for the study was received from the Malawi Health Sciences Research Committee (protocol number 419) and the ethics committee of the London School of Hygiene & Tropical Medicine.

Version history

  1. Received: September 27, 2013
  2. Accepted: December 2, 2013
  3. Version of Record published: January 28, 2014 (version 1)

Copyright

© 2014, Glynn et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,158
    views
  • 57
    downloads
  • 21
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Judith R Glynn
  2. Ndoliwe Kayuni
  3. Levie Gondwe
  4. Alison J Price
  5. Amelia C Crampin
(2014)
Earlier menarche is associated with a higher prevalence of Herpes simplex type-2 (HSV-2) in young women in rural Malawi
eLife 3:e01604.
https://doi.org/10.7554/eLife.01604

Share this article

https://doi.org/10.7554/eLife.01604

Further reading

    1. Epidemiology and Global Health
    Yuchen Zhang, Yitang Sun ... Kaixiong Ye
    Research Article

    Background:

    Circulating omega-3 and omega-6 polyunsaturated fatty acids (PUFAs) have been associated with various chronic diseases and mortality, but results are conflicting. Few studies examined the role of omega-6/omega-3 ratio in mortality.

    Methods:

    We investigated plasma omega-3 and omega-6 PUFAs and their ratio in relation to all-cause and cause-specific mortality in a large prospective cohort, the UK Biobank. Of 85,425 participants who had complete information on circulating PUFAs, 6461 died during follow-up, including 2794 from cancer and 1668 from cardiovascular disease (CVD). Associations were estimated by multivariable Cox proportional hazards regression with adjustment for relevant risk factors.

    Results:

    Risk for all three mortality outcomes increased as the ratio of omega-6/omega-3 PUFAs increased (all Ptrend <0.05). Comparing the highest to the lowest quintiles, individuals had 26% (95% CI, 15–38%) higher total mortality, 14% (95% CI, 0–31%) higher cancer mortality, and 31% (95% CI, 10–55%) higher CVD mortality. Moreover, omega-3 and omega-6 PUFAs in plasma were all inversely associated with all-cause, cancer, and CVD mortality, with omega-3 showing stronger effects.

    Conclusions:

    Using a population-based cohort in UK Biobank, our study revealed a strong association between the ratio of circulating omega-6/omega-3 PUFAs and the risk of all-cause, cancer, and CVD mortality.

    Funding:

    Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institute of Health under the award number R35GM143060 (KY). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

    1. Ecology
    2. Epidemiology and Global Health
    Aleksandra Kovacevic, David RM Smith ... Lulla Opatowski
    Research Article

    Non-pharmaceutical interventions implemented to block SARS-CoV-2 transmission in early 2020 led to global reductions in the incidence of invasive pneumococcal disease (IPD). By contrast, most European countries reported an increase in antibiotic resistance among invasive Streptococcus pneumoniae isolates from 2019 to 2020, while an increasing number of studies reported stable pneumococcal carriage prevalence over the same period. To disentangle the impacts of the COVID-19 pandemic on pneumococcal epidemiology in the community setting, we propose a mathematical model formalizing simultaneous transmission of SARS-CoV-2 and antibiotic-sensitive and -resistant strains of S. pneumoniae. To test hypotheses underlying these trends five mechanisms were built into the model and examined: (1) a population-wide reduction of antibiotic prescriptions in the community, (2) lockdown effect on pneumococcal transmission, (3) a reduced risk of developing an IPD due to the absence of common respiratory viruses, (4) community azithromycin use in COVID-19 infected individuals, (5) and a longer carriage duration of antibiotic-resistant pneumococcal strains. Among 31 possible pandemic scenarios involving mechanisms individually or in combination, model simulations surprisingly identified only two scenarios that reproduced the reported trends in the general population. They included factors (1), (3), and (4). These scenarios replicated a nearly 50% reduction in annual IPD, and an increase in antibiotic resistance from 20% to 22%, all while maintaining a relatively stable pneumococcal carriage. Exploring further, higher SARS-CoV-2 R0 values and synergistic within-host virus-bacteria interaction mechanisms could have additionally contributed to the observed antibiotic resistance increase. Our work demonstrates the utility of the mathematical modeling approach in unraveling the complex effects of the COVID-19 pandemic responses on AMR dynamics.